Search Tag: R&D

2021 30 Nov

GSK announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2021. Phil will report to Dr Hal Barron, Chief Scientific Officer and President R&D, and join GSK’s R&D Leadership Team, and the Vaccines Leadership Team. Phil will be based in Greater Boston, Massachusetts, US. Phil joins from Pfizer...Read more

2020 10 Apr

This week Cancer Research UK has announced that it has cut funding to its research activities. At the same time, the EU is aiming to raise around €2 billion in support of rapid response research initiatives to fight COVID-19.   You may also like: RECOVERY: World’s Largest COVID-19 Clinical Trial   Cancer Research UK is a fundraising...Read more